Rosana Maria dos Reis

Prof. Rosana Maria dos Reis

Associated professor, PhD
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2010 in Nature
Verified
Journal Article
Open access
PDF file
SASuneet Agarwal
Suneet Agarwal
YLYuinhan Hain Loh
Yuinhan Hain Loh
EMErin M. McLoughlin
Erin M. McLoughlin
JHJunjiu Huang
Junjiu Huang
IPIn-Hyun Park
In-Hyun Park
GDGeorge Q. Daley
George Q. Daley
Patients with dyskeratosis congenita, a disorder of telomere maintenance, suffer degeneration of multiple tissues. Agarwal et al. use iPS (induced pluripotent stem) cell technology to study the mechanisms underlying the disease in humans, and in doing so they discover that reprogramming restores telomere elongation in dyskeratosis congenita cells despite genetic lesions affecting telomerase. The reprogrammed dyskeratosis congenita cells were able to overcome a critical limitation in telomerase RNA component (TERC) levels to restore telomere maintenance and self-renewal, and multiple telomerase components are targeted by pluripotency-associated transcription factors. Strategies designed to increase TERC expression may therefore be therapeutically beneficial in dyskeratosis congenita patients. Here, iPS cell technology is used to study the mechanisms underlying dyskeratosis congenita in humans. Reprogramming restores telomere elongation in dyskeratosis congenita cells despite genetic lesions affecting telomerase. The reprogrammed cells were able to overcome a critical limitation in telomerase RNA component (TERC) levels to restore telomere maintenance and self-renewal, and multiple telomerase components are targeted by pluripotency-associated transcription factors. Patients with dyskeratosis congenita (DC), a disorder of telomere maintenance, suffer degeneration of multiple tissues1,2,3. Patient-specific induced pluripotent stem (iPS) cells4 represent invaluable in vitro models for human degenerative disorders like DC. A cardinal feature of iPS cells is acquisition of indefinite self-renewal capacity, which is accompanied by induction of the telomerase reverse transcriptase gene (TERT)5,6,7. We investigated whether defects in telomerase function would limit derivation and maintenance of iPS cells from patients with DC. Here we show that reprogrammed DC cells overcome a critical limitation in telomerase RNA component (TERC) levels to restore telomere maintenance and self-renewal. We discovered that TERC upregulation is a feature of the pluripotent state, that several telomerase components are targeted by pluripotency-associated transcription factors, and that in autosomal dominant DC, transcriptional silencing accompanies a 3′ deletion at the TERC locus. Our results demonstrate that reprogramming restores telomere elongation in DC cells despite genetic lesions affecting telomerase, and show that strategies to increase TERC expression may be therapeutically beneficial in DC patients.

1 August 2009 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
VGVinicius Guandalini Guapo
Vinicius Guandalini Guapo
FGFrederico Guilherme Graeff
Frederico Guilherme Graeff
AZAna Carolina Tagliati Zani
Ana Carolina Tagliati Zani
CLCybelli Morelo Labate
Cybelli Morelo Labate
Rosana Maria dos ReisRosana Maria dos Reis
Rosana Maria dos Reis
CDCristina Marta Del-Ben
Cristina Marta Del-Ben

1 June 2019 in Journal of Affective Disorders
Verified
Journal Article
Closed access
GKGislaine Satyko Kogure
Gislaine Satyko Kogure
VRVictor Barbosa Ribeiro
Victor Barbosa Ribeiro
ILIris Palma Lopes
Iris Palma Lopes
CFCristiana Libardi Miranda Furtado
Cristiana Libardi Miranda Furtado
SKSérgio Kodato
Sérgio Kodato
Rosana Maria dos ReisRosana Maria dos Reis
Rosana Maria dos Reis

23 June 2010 in Human Reproduction
Verified
Journal Article
Open access
PDF file
AMA. S. Melo
A. S. Melo
CVC. S. Vieira
C. S. Vieira
MBM. A. Barbieri
M. A. Barbieri
ARA. C. J. S. Rosa-E-Silva
A. C. J. S. Rosa-E-Silva
ASAntonio A Silva
Antonio A Silva
HBH. Bettiol
H. Bettiol
There is evidence that intrauterine growth restriction, resulting in newborn girls that are small for gestational age (SGA), may be related to the onset of polycystic ovary syndrome (PCOS). Thus, we studied whether women born SGA have a higher prevalence of PCOS than women born appropriate for gestational age (AGA). This was a prospective birth cohort study of 384 women born at term between June 1, 1978, and May 31, 1979, in Ribeirão Preto, Brazil. After exclusion, 165 women effectively participated in this study, of whom 43 were SGA and 122 were AGA. The prevalence of PCOS was analysed. At a mean age of 29 years, the women agreed to follow the study protocol, which included: anamnesis, physical examination, serum tests [follicle stimulating hormone, luteinizing hormone, total and free testosterone, dehydroepiandrostenedione sulphate, 17-OH-progesterone, fasting insulin, sex steroid-binding globulin (SHBG) and fasting glucose] and pelvic ultrasound. Data regarding gestational age, birthweight, age at menarche and maternal data were obtained from the files of the cohort. The adjusted relative risk (RR) values of the SGA, insulin resistance, body mass index, maternal smoking and parity variables were analysed using Poisson regression with robust adjustment of variance for the prediction of PCOS. The prevalence of PCOS was higher in the SGA group than in the AGA group [adjusted RR = 2.44, 95% CI (1.39–4.28)]. Hyperandrogenism was more prevalent in the SGA women than in the AGA women (P = 0.011). Circulating SHBG was lower in the SGA women than in the AGA women (P = 0.041), but fasting insulinemia was similar in both groups. The prevalence of PCOS in SGA women was twice as high as in AGA women in our study population.

14 August 2009 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
GSGustavo Mafaldo Soares
Gustavo Mafaldo Soares
CVCarolina Sales Vieira
Carolina Sales Vieira
WMWellington Paula Martins
Wellington Paula Martins
SFSílvio Antônio Franceschini
Sílvio Antônio Franceschini
Rosana Maria dos ReisRosana Maria dos Reis
Rosana Maria dos Reis
RFrui a ferriani
rui a ferriani

22 January 2015 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
RMRafael Mendes Moroni
Rafael Mendes Moroni
CVCarolina Sales Vieira
Carolina Sales Vieira
RFrui a ferriani
rui a ferriani
Rosana Maria dos ReisRosana Maria dos Reis
Rosana Maria dos Reis
ANAntonio Alberto Nogueira
Antonio Alberto Nogueira
LBLuiz Gustavo Oliveira Brito
Luiz Gustavo Oliveira Brito
Uterine leiomyoma is the most common gynecological tumor in the reproductive years. However, it is extremely rare in adolescence (<1%), with few reports found in the literature. The biological behavior of such tumors in this age group is unknown, as well as the best possible treatment for this population. We aimed to analyze all available reports of uterine leiomyoma in adolescence. A systematic review was performed at PubMed/MEDLINE and EMBASE. Between 1965 and 2014, 19 reports were found on uterine leiomyoma in patients under 18 years. The following parameters were discussed: age, tumor diameter, symptoms, clinical treatments, surgical treatments, hemodynamic changes. Mean age was 15.35 (14–17) years. Mean tumor diameter was 12.28 cm (3–30) and median diameter was 10 cm. Most patients presented with symptoms (87.5%), including abnormal uterine bleeding (10/18) and pelvic/abdominal pain (6/18). A pelvic mass was the most common finding. Two patients required transfusion due to anemia. One patient underwent abdominal hysterectomy, and the others underwent myomectomy. Mean follow-up was 1 year and 8 months, and only case recurred, after 6 months. Leiomyomas’ biologic behavior in adolescents may be different from that of older women, but their molecular characteristics still haven’t been analyzed. Optimal treatment is still not defined, but myomectomy has several advantages in this population. Leiomyomas must be remembered as an important differential diagnosis of pelvic mass in adolescents.